These Regulations amend the Medicines (Products for Human Use) (Fees) Regulations 2012 (“the 2012 Regulations”). The 2012 Regulations make provision for the fees payable under the Medicines Act 1971 and other fees payable in respect of EU obligations relating to marketing authorisations, licences and certificates in respect of medicinal products for human use.